GEN Exclusives

More »
New Products

Related to Refined Tools Aid in Pathway Analysis

    • Calcium Indicator Kit
    • Molecular Devices
    • The Fura-2 QBT Calcium kit combines the calcium indicator Fura-2 with masking technology to provide a ratiometric fluorescence-based assay for detecting and quantitating changes in intracellular calcium. The kit is designed to reduce background flu
    • Flow Cytometry Reagent Kits
    • Beckman Coulter
    • PerFix-Expose and PerFix-nc, reagent kits designed to reveal the cytoplasmic and nuclear compartments of the cell, were developed for use on Gallios and Navios series flow cytometers. With the PerFix-Expose (phospho-epitope exposure) kit, samples c
    • High-Content Imaging System
    • PerkinElmer
    • Live cell capabilities have been added to the Operetta system including brightfield imaging and environmental chamber options, as well as a transmitted light digital phase-contrast mode that can be used to image and segment live cells without using
    • Cheminformatics Software
    • Advanced Chemistry Development
    • The ChemAnalytical Workbook is an informatics tool designed for scientists who work with formulated products and complex mixtures. It is designed to enhance decision-making, reporting, and knowledge transfer through experiment, workflow, and data m
    • High-Content Imaging System
    • Molecular Devices
    • The ImageXpress® Micro XLS system can be used to carry out widefield, high-content screening in fixed-endpoint and time-lapse studies. With a screening capability of more than 50,000 wells per day, the system is designed to expedite the charac
  • Page 1 of 1 (6 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?